Agios Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $59.91 $119,820
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $62.07 $124,140
Option
SCHENKEIN DAVID P director
Common stock 6,000 $0.3 $1,818
Option
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $31.64 $67,899
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 6,000 $0.3 $1,818
Option
BILLER SCOTT officer: Chief Scientific Officer
Stock option (right to buy) 2,146 $31.64 $67,899
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $63.49 $136,256
Sale
SCHENKEIN DAVID P director
Common stock 6,000 $65.03 $390,198
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $71.1 $142,200
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $71.1 $142,200
Sale
SCHENKEIN DAVID P director
Common stock 80,000 $0.3 $24,240
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 10,470 $70 $732,900
Option
SCHENKEIN DAVID P director
Common stock 80,000 $0.3 $24,240
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 80,000 $0.3 $24,240
Option
SCHENKEIN DAVID P director
Common stock 6,000 $0.3 $1,818
Option
BILLER SCOTT officer: Chief Scientific Officer
Stock option (right to buy) 2,146 $38.14 $81,848
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 6,000 $0.3 $1,818
Option
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $38.14 $81,848
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 1,191 $9.05 $10,779
Sale
SCHENKEIN DAVID P director
Common stock 6,000 $0.3 $1,818
Option
SCHENKEIN DAVID P director
Common stock 35,000 $0.3 $10,605
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 35,000 $0.3 $10,605
Sale
SCHENKEIN DAVID P director
Common stock 35,000 $0.3 $10,605
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $65.71 $131,420
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $65.71 $131,420
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 15,000 $65 $975,000
Option
BOWDEN CHRISTOPHER officer: Chief Medical Officer
Stock option (right to buy) 6,000 $35.16 $210,960
Option
BOWDEN CHRISTOPHER officer: Chief Medical Officer
Common stock 6,000 $35.16 $210,960
Sale
BOWDEN CHRISTOPHER officer: Chief Medical Officer
Common stock 6,000 $35.16 $210,960
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 6,000 $0.3 $1,818
Sale
SCHENKEIN DAVID P director
Common stock 6,000 $0.3 $1,818
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $9.05 $19,421
Option
SCHENKEIN DAVID P director
Common stock 6,000 $0.3 $1,818
Option
BILLER SCOTT officer: Chief Scientific Officer
Stock option (right to buy) 2,146 $9.05 $19,421
Option
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $9.05 $19,421
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $57.07 $114,140
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $57.07 $114,140
Sale
SCHENKEIN DAVID P director
Common stock 24,000 $60.55 $1,453,200
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 24,000 $60.55 $1,453,200
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 21,000 $60.06 $1,261,260
Option
SCHENKEIN DAVID P director
Common stock 24,000 $60.55 $1,453,200
Option
BILLER SCOTT officer: Chief Scientific Officer
Stock option (right to buy) 2,146 $9.05 $19,421
Option
SCHENKEIN DAVID P director
Common stock 3,000 $0.3 $909
Sale
SCHENKEIN DAVID P director
Common stock 3,000 $0.3 $909
Option
SCHENKEIN DAVID P director
Stock option (right to buy) 3,000 $0.3 $909
Sale
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $9.05 $19,421
Option
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $9.05 $19,421
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 2,000 $57.13 $114,260
Sale
CANTLEY LEWIS CLAYTON JR. director
Common stock 7,000 $56.64 $396,480
Option
BILLER SCOTT officer: Chief Scientific Officer
Common stock 2,146 $9.05 $19,421

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.